n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide has been researched along with Sarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dittrich, C; Gneist, M; Huitema, AD; King, AA; Wanders, J; Zandvliet, AS | 1 |
1 trial(s) available for n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide and Sarcoma
Article | Year |
---|---|
A phase I and pharmacokinetic study of indisulam in combination with carboplatin.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Neutropenia; Sarcoma; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2007 |